America records over 1 million excess deaths among the over 65 years old since beginning of covid vaccine rollout

The United States has registered over one million excess deaths among those over 65 years old since the Food and Drug Administration (FDA) approved the first Wuhan coronavirus (covid) vaccines more than three years ago.

The FDA issued the Emergency Use Authorization (EUA) for the Pfizer-BioNTech covid vaccine on Dec. 11, 2020, making it the first such jab to secure authorization in the United States. After this the Moderna covid vaccine obtained an EUA on Dec. 18, 2020, and the Janssen (Johnson & Johnson) injection received EUA on Feb. 27, 2021.

The elderly were given the covid vaccine first and the number of excess deaths registered afterwards was astonishing.

During the first 20 weeks of 2021, 150,085 excess deaths were reported among people aged over 65 years old compared to the 2015 to 2019 five-year average.

Then from week 21 to week 40 of 2021, a stunning 165,387 excess deaths were registered among people aged 65 and over.

This brought the total excess deaths from week 1 to week 40 of 2021 to 315,472 among those most likely to receive the covid vaccine.

The remainder of 2021 witnessed 133,268 excess deaths recorded which brought the total excess deaths for the year among people aged over 65 to 448,740.

“This means nearly half a million more people died than expected who were aged 65 and over during a period where excess deaths were supposed to be reduced dramatically because an apparently safe and effective vaccine was being administered to stop a wave of deaths supposedly caused by a deadly pandemic,” wrote The Expose in a report on excess deaths due to the covid vaccine.

The year 2022 improved a little, but still saw a surprising number of excess deaths with 371,466 reported among those aged over 65.

Last year, 257,415 excess deaths were registered among those aged 65 and over, with the most recent data issued by the Centers for Disease Control and Prevention confirming 5,482 excess deaths were reported in week 1 of 2024.

“This means that in total, 1,069,943 excess deaths were recorded among people aged over 65 from the first time they were offered the covid vaccine to week 1 of 2024,” The Expose reported.

“This is a shocking number of excess deaths compared to the 2015-2019, five-year average. The covid vaccines were supposed to reduce the number of people dying, not increase it.”

The overwhelming number of excess deaths reaching over one million in three years is sufficient evidence that the covid vaccines are far from safe and effective.

The quietly issued numbers prove that they are exceedingly dangerous.

Americans over 65 years old “prioritized” to receive covid vaccines

In America, people over the age of 65 years old have been provided many covid vaccines under emergency use authorization (EUA).

They had been prioritized to receive the vaccines because of their alleged higher risk of serious illness from covid.

Booster doses had also been suggested because the vaccines clearly didn’t work. If they did, there would never be over one million excess deaths among those who have had more injections than any other age group.

This data isn’t only showing up in America because most of the Western world have shown a significant increase in excess deaths.

RIGGED MEDICINE: Report finds nearly 60% of U.S. doctors received payments totaling over $12 billion from Big Pharma firms between 2013 and 2022

A report has found that nearly six in 10 doctors in the United States received payments from Big Pharma firms between 2013 and 2022.

This is according to a study done by researchers at Pennsylvania State University, which found that around 57 percent of doctors collectively received approximately $12.1 billion from medical device manufacturers and pharmaceutical drug makers between 2013 and 2022.

“Despite evidence that financial conflicts of interest may influence physician prescribing and may damage patients’ trust in medical professionals, such payments remain pervasive,” the researchers wrote.

The researchers used data from the platform Open Payments – a publicly accessible national database where drug and medical device companies disclose payments and gifts made to physicians – for their study. They found that from August 2013 to August 2022, American drug and device manufacturers made more than 85 million individual payments to 826,313 of the more than 1.4 million eligible doctors in the United States.

The payments that the researchers included in their study were both in cash and non-cash equivalents. Most went to consulting services and non-consulting fees, such as payments for serving as a speaker. Physicians were also showered with food and beverages, travel and lodging, entertainment, education, grants, charitable contributions, honoraria and other kinds of non-cash gifts.

Orthopedic surgeons received largest total sum

Thirty-nine medical specialties were analyzed in the study and the researchers found that orthopedic surgeons received the largest total sum of payments, at $1.36 billion. After orthopedic surgeons, the specialties that received the largest total sum of payments were neurologists and psychiatrists, who received $1.32 billion, and cardiologists, who received $1.29 billion.

Although the median payment to doctors was $48, payments to the top 0.1 percent of doctors were far higher and differed depending on specialty. The average amount paid to this top class of physician was $4,826,944 for orthopedic surgeons, $3,197,675 for cardiologists and $2,588,819 for neurologists and psychiatrists.

Other major earning specialties include hematology and oncology ($825 million), internal medicine ($588 million), endocrinology ($546 million), family medicine ($479 million), rheumatology, allergy and immunology ($464 million), dermatology ($462 million) and gastroenterology ($441 million). The lowest earners were pediatricians.

Twenty-five drugs and medical devices were associated with the largest payments. Roughly 94 percent of payments were associated with one or more of the 25 marketed medical products.

For drugs, the largest payments were for the blood thinners rivaroxaban – sold by Bayer under the brand name Xarelto – and apixaban – sold by Pfizer as Eliquis. Both are medicines used to prevent blood clots and stroke in people with atrial fibrillation.

They were followed by the psoriasis drug adalimumab, sold by AbbVie as Humira; and canaglifozin and empagliflozin, both used to treat Type 2 diabetes. The former is sold by Johnson & Johnson as Invokana and the latter by Eli Lilly as Jardiance.

The top medical device related to industry payment was the Da Vinci surgical system – a robotic surgical system. More than 60,000 surgeons globally are trained on the Da Vinci, and manufacturer Intuitive Surgical is on an aggressive campaign to get more surgeons to train to use it.

 

yogaesoteric
April 10, 2024